Revive Therapeutics Ltd (RVVTF)

[Classic Warrior]

I don't get the PR. It tells us nothing other than Revive is still looking at the data, considering an endpoint change and a possible EUA to the FDA, Although some may find it reassuring that things are moving forward, clearly the market has spoken. There will be no news for weeks now because if they were at the tail end and getting ready to submit data, no PR like this would come out.

The rebound from $.26 was reassuring, and I will take away a positive that it is a small drop considering that so many of us were expecting this PR to be much more positive.

So you know what we do. Sell? Hell no- we wait.

ps. I suspect many sellers today will jump back in as soon as trial data is submitted even if they lose a few cents in the process.